National Institutes of Health researchers and collaborators have discovered over 100 new regions of the human genome, also ...

One of the largest genomics studies into blood pressure has revealed 100 new regions of the genome that influence blood ...

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy ...

The crystal structure of a second G protein–coupled receptor sheds light on these key pharmaceutical targets. In contrast, β2AR and essentially all of the other GPCRs are present at very low ...

Hypertension: By combining the therapeutic benefits of calcium channel blockers, angiotensin II receptor antagonists, and ...

“These medications act on adrenergic receptors on the blood vessels that line the nose’s mucous membranes. If you take the spray around the clock for many days in a row, those receptors get ...

Vibegron is a potent and selective human beta-3 adrenergic receptor (β3-AR) agonist. The positive opinion is a significant step towards marketing authorisation from the European Commission for OBGEMSA ...

adrenergic receptor blocking agent that slows the sinus rate and decreases AV nodal conduction. The β-blocking activity of metoprolol has been shown by reduction in heart rate and cardiac output ...

Akums Drugs and Pharmaceuticals on Thursday launched Amlodipine, Telmisartan & Metoprolol (ER) film-coated tablets, a ...

Study in the journal Nutrients links exposure to endocrine-disrupting chemicals with vitamin D deficiency and reduced sleep ...

Discover how Vanda Pharmaceuticals' patent revolutionizes circadian rhythm disorder treatment with tasimelteon, tailored to patients' beta-adrenergic receptor antagonist use.